High-Risk Acute Promyelocytic Leukemia with Early Differentiation Syndrome: A Therapeutic Dilemma

Publisher： Karger

E-ISSN： 1421-9662|127|1|60-62

ISSN： 0001-5792

Source： Acta Haematologica, Vol.127, Iss.1, 2011-11, pp. : 60-62

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Idarubicin, cytarabine, and pravastatin as induction therapy for untreated acute myeloid leukemia and high‐risk myelodysplastic syndrome

By  

AMERICAN JOURNAL OF HEMATOLOGY, Vol. 90, Iss. 6, 2015-06 ,pp. : 483-486

John Wiley & Sons Inc

Access to resources Recommend Favorite

Coagulopathy of Acute Promyelocytic Leukemia

By  

Acta Haematologica, Vol. 106, Iss. 1-2, 2001-09 ,pp. : 43-51

Karger

Access to resources Recommend Favorite

Acute Promyelocytic Leukemia with a Smoldering Course Associated with Therapy-Related Myelodysplastic Syndrome

By  

Acta Haematologica, Vol. 126, Iss. 3, 2011-07 ,pp. : 152-156

Karger

Access to resources Recommend Favorite

Treatment of Relapsed Acute Promyelocytic Leukemia

By  

Oncology Research and Treatment, Vol. 26, Iss. 4, 2003-09 ,pp. : 373-379

Karger

Access to resources Recommend Favorite

Acute Promyelocytic Leukemia-Associated Thrombosis

By  

Acta Haematologica, Vol. 130, Iss. 1, 2013-03 ,pp. : 1-6

Karger

Access to resources Recommend Favorite